Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes

Meng Yu Wu, Chung Chi Huang, Tzu I. Wu, Chin Liang Wang, Pyng Jing Lin

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)


Despite a therapeutic option for severe acute respiratory distress syndrome (ARDS), the survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) is still controversial in adults. This study was aimed at investigating the prognostic factors for ECMO-treated ARDS in adult patients. From 2012 to 2015, 49 patients (median age: 57 years) received VVECMO in our institution and were included in this retrospective study. The indication of VV-ECMO was a severe hypoxemia (PaO2/FiO2 ratio <70 mmHg) under mechanical ventilation (MV) with a peak inspiratory pressure (PIP) >35cmH2O and a FiO2 >0.8. To decrease the impact of pulmonary injuries associated with the high-pressure ventilation, the settings of MV on VV-ECMO were downgraded accorDing to our protocol. Outcomes of this study were death on VV-ECMO and death in hospital. Important demographic and clinical data during the treatment were collected for outcome analyses. All patients experienced significant improvements in arterial oxygenation onVV-ECMO.Twenty-four hours after initiation ofVV-ECMO, the median PaO2/FiO2 ratio increased from 58 to 172mmHg (P<0.001) and the median SaO2 increased from 86% to 97% (P<0.001). In the meantime, theMVsettings were also effectively downgraded. The median PIP decreased from 35 to 29cmH2O (P<0.001) and the median tidal volume decreased from 7 to 5 ml/kg/min (P<0.001). Twelve patients died during the treatment of VV-ECMO and 21 patients died before hospital discharge. Among all of the pre-ECMOvariables, the pre-ECMOpulmonary dynamic compliance (PCdyn) <20mL/cmH2O was identified to be the prognostic factor of death on VV-ECMO (odds ratio [OR]: 6, 95% confidence interval [CI]: 1-35, P<0.03), and the pre-ECMO duration of MV >90 hours was the prognostic factor of death before hospital discharge (OR: 7, 95% CI: 1-29, P<0.01). VV-ECMO was a useful salvage therapy for severe ARDS in adults. However, the value of PCdyn and the duration of MV before intervention with VV-ECMO may significantly affect the patients' outcomes.

Original languageEnglish
Article numbere2870
JournalMedicine (United States)
Issue number8
Publication statusPublished - Mar 4 2016

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome in adults prognostic factors for outcomes'. Together they form a unique fingerprint.

Cite this